Skip to content

Evaluation of the Effectiveness of Vibroacoustic Therapy in the Complex Treatment of Acute Respiratory Failure

Assessing the Ventilatory Parameters in Patients With Acute Respiratory Failure After Vibroacoustic Pulmonary Therapy.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03911947
Enrollment
113
Registered
2019-04-11
Start date
2019-05-02
Completion date
2020-07-31
Last updated
2021-01-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Respiratory Failure

Keywords

Vibroacoustic therapy, acute respiratory failure, pneumonia

Brief summary

Evaluation of the effectiveness of vibroacoustic therapy in the complex treatment of acute respiratory failure

Detailed description

Assessing the dynamics of changes in physical, instrumental and laboratory parameters in patients with acute respiratory failure taken in the study according to the inclusion criteria and comparing the results with the control group, studying the effectiveness of vibroacoustic lung therapy.

Interventions

DEVICEVibrolung

Device for vibroacoustic respiratory therapy

Sponsors

Astana Medical University
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

monitoring of treatment of patients with respiratory failure, the list of therapeutic measures which includes vibroacoustic therapy

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* adults * P/F less 300 torr * ARDS by Berlin convention

Exclusion criteria

* children * acute stroke * acute coronary syndrome * DVT * implanted pacemaker * rib fracture * infection on chest

Design outcomes

Primary

MeasureTime frameDescription
Change of time spent on ventilation1-2 daysChanging of the time spent by patients on mechanical ventilation

Countries

Kazakhstan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026